Recent breakthroughs in the field of obesity treatment have presented a new therapy known as ALLUVI Retatrutide. This compound is a {highlypotent GLP-1 receptor agonist, formulated to stimulate the effects of natural glucagon-like peptide-1. Retatrutide has shown remarkable outcomes in clinical trials, demonstrating significant reductions in body w